Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SVB Leerink

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$159M
Portfolio companies 3
Rounds per year 0.11
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Information Technology
  • Developer Platform
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SVB Leerink:
Typical Co-investors
SVB Leerink is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SVB Leerink:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ASE Global Group New York, New York, United States
Care Capital New Jersey, Princeton, United States
Edison International California, Rosemead, United States
First Reserve Corporation Connecticut, Greenwich, United States
Hengqinhexiang Venture China, Guangdong, Zhuhai
Hims & Hers California, San Francisco, United States
HTG Japan, Osaka, Osaka Prefecture
ITI Energy -
Key Venture Partners Boston, Massachusetts, United States
Lucent Venture Partners California, Palo Alto, United States
Muniu Touzi China, Guangdong, Shenzhen
Rockefeller Financial Services California, Los Angeles, United States
Septeni Chiyoda, Japan
Start it Labs, LLC Bellevue, United States, Washington
Strandview Capital California, El Segundo, United States
UBS Asset Management England, London, United Kingdom
Waaree India, Maharashtra, Mumbai
Walmart Arkansas, Bentonville, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Odyssey Therapeutics

Biotechnology
Health Care
$168M13 Oct 2022 Cambridge, Massachusetts, United States

Umoja Biopharma

Biopharma
Biotechnology
Developer Platform
Information Technology
$210M15 Jun 2021 Seattle, Washington, United States

Biotechnology
Health Care
Therapeutics
$100M14 Dec 2020 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SVB Leerink?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 159M
Rounds per year 0.11
Peak activity year 2021
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Odyssey Therapeutics

Biotechnology
Health Care
$168M13 Oct 2022 Cambridge, Massachusetts, United States

Umoja Biopharma

Biopharma
Biotechnology
Developer Platform
Information Technology
$210M15 Jun 2021 Seattle, Washington, United States

Biotechnology
Health Care
Therapeutics
$100M14 Dec 2020 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: